Clinical trial
Cross Over Study to Assess the Effect of the Nasal Gel "Nascum®-Plus" on Allergic Symptoms and Inflammatory Cells and Cytokines During and After Allergen Challenge in the Fraunhofer Allergen Challenge Chamber (ACC)
NCT03772405 is registered in ClinicalTrials.gov with Fraunhofer-Institute of Toxicology and Experimental Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cross Over Study to Assess the Effect of the Nasal Gel "Nascum®-Plus" on Allergic Symptoms and Inflammatory Cells and Cytokines During and After Allergen Challenge in the Fraunhofer Allergen Challenge Chamber (ACC)
- Lead sponsor
- Fraunhofer-Institute of Toxicology and Experimental Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 12, 2018
- Completion date
- February 1, 2019
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.